Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo�…

TA Horoiwa, M Cortez, IP Sauter, A Migotto…�- European Journal of�…, 2020 - Elsevier
The leishmaniases are a group of diseases caused by protozoan parasites from Leishmania
species. Effectiveness therapies for cutaneous leishmaniasis (CL), the most common form�…
Save Cite Cited by 19 Related articles

Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo�…

TA Horoiwa, M Cortez, IP Sauter…�- …�: official journal of�…, 2020 - pubmed.ncbi.nlm.nih.gov
The leishmaniases are a group of diseases caused by protozoan parasites from Leishmania
species. Effectiveness therapies for cutaneous leishmaniasis (CL), the most common form�…
Cite

Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo�…

TA Horoiwa, M Cortez, IP Sauter, A Migotto… - 2020 - cabidigitallibrary.org
The leishmaniases are a group of diseases caused by protozoan parasites from Leishmania
species. Effectiveness therapies for cutaneous leishmaniasis (CL), the most common form�…
Cite

[CITATION][C] Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: ex vivo cutaneous retention and�…

T Arag�o Horoiwa, M Cortez…�- European Journal�…, 2020 - espace.library.uq.edu.au
The leishmaniases are a group of diseases caused by protozoan parasites from Leishmania
species. Effectiveness therapies for cutaneous leishmaniasis (CL), the most common form�…
Cite

[CITATION][C] Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and�…

TA Horoiwa, MJC Veliz, IP Sauter…�- European Journal of�…, 2020 - repositorio.usp.br
ReP USP - Detalhe do registro: Sugar-based colloidal nanocarriers for topical meglumine
antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention�…
Cite

Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo�…

M Cortez, IP Sauter, A Migotto, CL Bandeira…�- European Journal of�…, 2020 - europepmc.org
The leishmaniases are a group of diseases caused by protozoan parasites from Leishmania
species. Effectiveness therapies for cutaneous leishmaniasis (CL), the most common form�…
Cite